CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease...
Phase 3
Salt Lake City, Utah, United States and 43 other locations
This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled multicenter study to investigate outcomes with elecoglipron compare...
Phase 3
South Salt Lake, Utah, United States and 425 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
South Salt Lake, Utah, United States and 297 other locations
This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medici...
Phase 3
Salt Lake City, Utah, United States and 98 other locations
To evaluate the pharmacodynamics and safety of tolvaptan in pediatric subjects with ARPKD
Phase 3
Salt Lake City, Utah, United States and 22 other locations
and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney...
Phase 3
South Salt Lake, Utah, United States and 757 other locations
Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...
Phase 3
Salt Lake City, Utah, United States and 133 other locations
Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...
Phase 3
Salt Lake City, Utah, United States and 134 other locations
of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/ ...
Phase 3
Salt Lake City, Utah, United States and 762 other locations
The purpose of this study is to measure the efficacy and safety of baxdrostat/dapagliflozin in participants ≥ 18 years of age with CKD and HTN.This s...
Phase 3
Salt Lake City, Utah, United States and 565 other locations
Clinical trials
Research sites
Resources
Legal